Problems of in vitro Antibiotic Susceptibility Compliance with Efficacy of Chemotherapy in Infections Due to Pathogenic Burkholderias
Abstract
Among the known species of Burkholderia only two are obligate pathogens, i. e. B.mallei and B.pseudomallei, causative agents of glanders and melioidosis respectively. The other species are saprophytes as natural inhabitants of water reservoirs and soil, still capable of causing opportunistic infections in humans and animals under definite conditions. All the species of Burkholderia are characterized by high resistance to antibacterials, including antibiotics. By the MICs, the most efficient chemotherapeutics against pathogenic burkholderias are tetracyclines, fluoroquinolones, penems and combined sulfanilamides. In the treatment of experimental glanders and melioidosis the set of the effective drugs had the inverse variation dependence on the infection severity and the desease process rate. Co-trimoxasole showed the best results, then followed doxicycline, ciprofloxacin and ceftazidime in the diminishing succession. The modification of the method for determination of antibiotic susceptibility with addition of native blood to the medium and the subculture under the atmosphere of 5% CO2 was shown useful in estimation of the prospects of the use of chemotherapeutics for the treatment of Burkholderia infections.
About the Authors
V. I. Ilyukhin
Research Antiplague Institute, Volgograd
Russian Federation
Russian Federation
T. V. Senina
Research Antiplague Institute, Volgograd
Russian Federation
Russian Federation
M. N. Trushkina
Research Antiplague Institute, Volgograd
Russian Federation
Russian Federation
E. V. Shubnikova
Research Antiplague Institute, Volgograd
Russian Federation
Russian Federation
YU. V. Antonov
Research Antiplague Institute, Volgograd
Russian Federation
Russian Federation
N. V. Andropova
Research Antiplague Institute, Volgograd
Russian Federation
Russian Federation
References
1. Cheng A. C., Currie B. J. Melioidosis: epidemiology, pathophysiology and management. Clin Microbiol Rev 2005; 18: 383—416.
2. Waag D. M., Deshazer D. Glanders. New insights into an old disease. In: Infectious Disease: Ed. by L. E. Lindler, F. J. Lebeda, G. W. Korch, N. J. 2004; 209—237.
3. Илюхин В. И., Сенина Т. В., Плеханова Н. Г. и др. Burkholderia thailandensis: биологические свойства, идентификация и таксономическая позиция. Мол. генет., микробиол. и вирусол. 2002; 1: 7—11.
4. Антонов В. А., Илюхин В. И., Сенина Т. В. и др. Фенотипическая и генотипическая идентификация бактерий комплекса Burkholderia cepacia Журн микробиол эпидемиол иммунол 2008; 4: 78—82.
5. Gibson R. L., Burns J. L., Ramsey B. W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Resp Crit Care Med.2003; 168: 918—951.
6. Илюхин В. И., Алексеев В. В., Антонов Ю. В. и др. Эффективность лечения экспериментального сапа при аэрогенном заражении. Антибиотики и химиотер 1994; 9—10: 45—48.
7. Corkill J. E., Deveney J., Pratt J. Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams. Pediatr Res 1994; 35: 3: 299—302.
8. Walsh A. L., Smith M. D., Wuthiekanum V., White N. J. Postantibiotic effect and Burkholderia (Pseudomonas) pseudomallei: an evaluation of current treatment. Antimicrob Agents Chemother 1995; 39: 2356—2358.
9. Илюхин В. И., Батманов В. П. Влияние температуры и рН среды по чувствительности патогенных псевдомонад к химиопрепаратам. Антибиотики и химиотер1997; 4: 21—23.
10. Ericsson H. M., Sherris J. C. Antibiotic sensitivity testing. Acta Pathol et Microbiol Scand 1971; 217: 1—90.
11. Russell P., Eley S. M., Ellis J. et al. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. J Antimicrob Chemother 2000; 45: 813—818.
12. Ашмарин И. П., Воробьев А. А. Статистические методы в микробиологических исследованиях. М.: 1962;180.
13. Антонов Ю. В., Илюхин В. И., Поповцева Л. Д. и др. Чувствительность псевдомонад к современным антибактериальным препаратам. Антибиотики 1991; 1: 14—16.
14. Kenny D. L., Russell P., Rogers D. et al. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob Agents Chemother 1999; 43: 11: 2773—2775.
15. Thibault F. M., Hernande Z. E., Vidal D. R. et al. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. Ibod 2004; 54: 1134—1138.
16. Навашин С. М., Фомина И. П., Архангельский А. М. и др. Инструкция по единой методике экспериментального изучения и клинических испытаний новых антибиотиков и химиопрепаратов для экстренной профилактики и лечения опасных инфекционных заболеваний. М.: 1980; 15.
Review
For citations:
Ilyukhin V.I., Senina T.V., Trushkina M.N., Shubnikova E.V., Antonov Yu.V., Andropova N.V. Problems of in vitro Antibiotic Susceptibility Compliance with Efficacy of Chemotherapy in Infections Due to Pathogenic Burkholderias. Antibiot Khimioter = Antibiotics and Chemotherapy. 2009;54(7-8):19-23. (In Russ.)
Views:
303
Email this article 